Clinical Trial Update: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research [EARLY_Phase 1]

View source ↗

Summary

This early-phase (Phase 1) clinical trial investigates the safety and preliminary efficacy of Meta10-19 metabolically armed CD19 CAR-T cells in relapsed/refract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Meta10-19 (metabolically armed CD19 CAR-T cells)

Snippet

Sponsor: He Huang | Conditions: Diffuse Large B-cell Lymphoma | EARLY_Phase 1 | Status: RECRUITING